The effects of dopamine, dobutamine and amrinone on mitochondrial function in cardiogenic shock

Japanese Heart Journal

Volumn 38, Issue 4, 1997, Pages 515-529

  Mukae, Shuji ^a   Yanagishita, Toshikuni ^a   Geshi, Eiichi ^a   Umetsu, Kazuhiko ^a   Tomita, Masataka ^a   Itoh, Seiji ^a   Konno, Noburu ^a   Katagiri, Takashi ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Amrinone; Cardiogenic shock; Dobutamine; Dopamine; Mitochondria

Indexed keywords

AMRINONE; DOBUTAMINE; DOPAMINE;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; DOG; ELECTRON MICROSCOPY; HEART FUNCTION; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE BLOOD FLOW; HEART OUTPUT; HEMODYNAMICS; LEFT CORONARY ARTERY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0030805519     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/ihj.38.515     Document Type: Article

References (35)

1. Robert R. Inotropic therapy for cardiac failure associated with acute myocardial infarction. Chest 1988; 93: 22S-24S.
2. Benotti JR, McCau JE, Alpert JS. Comparative vasoactive therapy for heart failure. Am J Cardiol 1985; 56: 193-243.
3. Uretsky BF, Lawless CE, Verbalis JG, Valdes AM, Kolesar JA, Reddy PS. Combined therapy with dobutamine and amrinone in severe heart failure. Chest 1987; 92: 657-62.
4. Sorensen EV, Nielsen-Kudsk F. Myocardial pharmacodynamics of dopamine, dobutamine, amrinone and isoprenaline compared in the isolated rabbit heart. Eur J Pharmacol 1986; 124: 51-7.
5. Katz AM. Are inotropic agents contraindicated in congestive heart failure? Cardiovasc Drugs Ther 1989; 2: 747-50.
6. Dhalla NS, Yates JC, Lee SL, Singh A. Functional and subcellular changes in the isolated rat heart perfused with oxidized isoproterenol. J Mol Cell Cardiol 1978; 10: 31-41.
7. Mizutani T, Hazeki T. A study of system and regional hemodynamic changes in experimental myocardial infarction, with reference to the effects of catecholamine. Jpn Circ J 1974; 38: 479-83.
8. Sordahl LA, Stewart ML. Mechanisms of altered mitochondrial calcium transport in acutely ischemic canine hearts. Circ Res 1980; 47: 814-20.
9. Hagihara B. Techniques for the application of polarography to mitochondrial respiration. Biochem Biophys Acta 1961; 46: 134-42.
10. Chance B. The energy-linked reaction of calcium with mitochondria. J Biol Chem 1965; 240: 2729-48.
11. Hatefi Y, Rieske JS. Preparation and properties of DPNH-coenzyme Q reductase (complex I of the respiratory chain). Methods in Enzymology 1967; 10: 235-9.
12. Ziegler D, Rieske JS. Preparation and properties of succinate dehydrogenase-coenzyme Q reductase (complex II). Methods in Enzymology 1967; 10: 231-5.
13. Orii Y, Okunuki K. Studies on cytochrome a. XV. Cytochrome oxidase activity of the Okunuki preparation and its activation by heat, alkali and detergent treatments. J Biochem 1965; 58: 561-8.
14. Pullman ME, Penefsky HS, Datta A, Racker E. Partial resolution of the enzymes catalyzing oxidative phosphorylation. 1. Purification and properties of soluble dinitrophenol-stimulated adenosine triphosphatase. J Biol Chem 1960; 235: 3322-9.
15. Geshi E, Konno N, Yanagishita T, Katagiri T. Impairment of mitochondrial respiratory activity in the early ischemic myocardium. Jpn Circ J 1988; 52: 535-42.
16. Rouslin W. Mitochondrial complex I, II, III, IV and V in myocardial ischemia and autolysis. Am J Physiol 1983; 244: H743-H748.
17. Unverferth DV, Leier CV, Magorien RD, et al. Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study. J Pharmacol Exp Ther 1980; 215: 527-32.
18. Ozawa K, Takeyama Y, Katagiri T. Electron microscopic studies on the ATPase activity in myocardial infarction. Jpn Circ J 1982; 46: 725-33.
19. Page DL, Caulfield JB, Kastor JA, Desanctis RW, Sanders CA. Myocardial changes associated with cardiogenic shock. New Engl J Med 1971; 285: 133-7.
20. Swan HJC, Forrestor JS, Diamond G, Chatterjee K, Parmley WW. Hemodynamic spectrum of myocardial infarction and cardiogenic shock. Circulation 1972; 45: 1097-110.
21. Alonso DR, Scheidt S, Post M, Killip T. Pathophysiology of cardiogenic shock: quantification of myocardial necrosis, clinical, pathologic and electrocardiographic correlation. Circulation 1973; 48: 588-96.
22. Kurland GS, Weingarten C, Pitt B. The relation between the location of coronary occlusions and the occurrence of shock in acute myocardial infarction. Circulation 1965; 31: 646-50.
23. Wyatt HL, Forrester JS, Luz PL, Diamond GA, Chagrasulis R, Swan HJC. Functional abnormalities in nonoccluded regions of myocardium after experimental coronary occlusion. Am J Cardiol 1976; 37: 366-72.
24. Vikhert AM, Cherpachenko NM. Changes in metabolism of undamaged sections of myocardium following infarction. Circ Res 1974; 35: III-182-III-191.
25. Mochizuki M, Konno N, Umetsu K, Katagiri T. Metabolic changes in the non-ischemic myocardium under pump failure complicated in acute myocardial infarction. J Showa Med Assoc 1988; 48: 95-103.
26. Mukae S, Geshi E, Mochizuki M, Katagiri T. Impairment of mitochondrial respiratory activity of non-infarcted myocardium under severe pump failure in acute myocardial infarction. Jpn Circ J 1991; 55: 835-44.
27. Horwitz D, Fox SM, Goldberg LI. Effects of dopamine in man. Circ Res 1962; 10: 237-43.
28. Tuttle RR. Dobutamine. Circ Res 1975; 36: 185-96.
29. Sys SU, Boels PJ, Brutsaert DL. Positive inotropic and vasodilatory effects of amrinone and milninone in isolated canine heart. J Cardiovasc Pharmacol 1987; 10: 445-9.
30. Morner SEJN, Canepari M, Bottinelli R, Cappelli V, Reggiani C. Effects of amrinone on shortening velocity, force development and ATPase activity of demembranated preparations of rat ventricular myocardium. Acta Physiol Scand 1992; 146: 21-30.
31. Bobyleva-Guarriero V, Mussini C, Muscatello U, Cappello C, Mattioli G. Effect of amrinone on myocardial mitochondria function. FEBS Lett 1988; 233: 400-2.
32. Butterworth JF, Zaloga GP, Prielipp RC, Tucker WY, Royster RL. Calcium inhibits the cardiac stimulating properties of dobutamine but not of amrinone. Chest 1992; 101: 174-80.
33. Dupuis JY, Bondy R, Cattran C, Nathan HJ, Wynands JE. Amrinone and dobutamine as primary-treatment of low cardiac output syndrome following coronary artery surgery: a comparison of their effects on hemodynamics and outcome. J Cardiothor Vaso Anesth 1992; 6: 542-53.
34. Baim DS. Effect of phosphodiesterase inhibition on myocardial oxygen consumption and coronary blood flow. Am J Cardiol 1989; 63: 23A-26A.
35. 2+ in the regulation of oxidative phosphorylation in the stimulated rat heart. Biochem J 1989; 262: 293-301.